BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38216200)

  • 1. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids.
    Al-Hendy A; Segars JH; Taylor HS; González F; Siblini H; Zamah M; Alkelani H; Singh B; Flores VA; Christman GM; Johnson JJ; Huang H; Zhang H
    BMJ Open; 2024 Jan; 14(1):e078989. PubMed ID: 38216200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
    Siblini H; Al-Hendy A; Segars J; González F; Taylor HS; Singh B; Flaminia A; Flores VA; Christman GM; Huang H; Johnson JJ; Zhang H
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.
    Styer AK; Jin S; Liu D; Wang B; Polotsky AJ; Christianson MS; Vitek W; Engmann L; Hansen K; Wild R; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Christy A; Diamond MP; Eisenberg E; Zhang H; Santoro N;
    Fertil Steril; 2017 Mar; 107(3):756-762.e3. PubMed ID: 28089575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; van Wessel S; Weyers S; Broekmans FJ; D'Hooghe TM; Bongers MY; Mol BWJ
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009461. PubMed ID: 30521679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; Kasius J; Weyers S; Broekmans FJ; Mol BW; D'Hooghe TM
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009461. PubMed ID: 25701429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-uterine insemination for unexplained subfertility.
    Ayeleke RO; Asseler JD; Cohlen BJ; Veltman-Verhulst SM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001838. PubMed ID: 32124980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial.
    Taylor H; Li HJ; Carson S; Flores V; Pal L; Robbins J; Santoro NF; Segars JH; Seifer D; Huang H; Young S; Zhang H
    BMJ Open; 2022 Jun; 12(6):e052043. PubMed ID: 35715184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities.
    Bosteels J; Kasius J; Weyers S; Broekmans FJ; Mol BW; D'Hooghe TM
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009461. PubMed ID: 23440838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-uterine insemination for unexplained subfertility.
    Veltman-Verhulst SM; Hughes E; Ayeleke RO; Cohlen BJ
    Cochrane Database Syst Rev; 2016 Feb; 2():CD001838. PubMed ID: 26892070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Vale L; Templeton A
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial.
    Hansen KR; Peck JD; Coward RM; Wild RA; Trussell JC; Krawetz SA; Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Santoro N; Zhang H
    Hum Reprod; 2020 Jun; 35(6):1296-1305. PubMed ID: 32432326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-uterine insemination for unexplained subfertility.
    Veltman-Verhulst SM; Cohlen BJ; Hughes E; Heineman MJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD001838. PubMed ID: 22972053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.
    Danhof NA; van Wely M; Koks CAM; Gianotten J; de Bruin JP; Cohlen BJ; van der Ham DP; Klijn NF; van Hooff MHA; Broekmans FJM; Fleischer K; Janssen CAH; Rijn van Weert JM; van Disseldorp J; Twisk M; Traas M; Verberg MFG; Pelinck MJ; Visser J; Perquin DAM; Boks DES; Verhoeve HR; van Heteren CF; Mol BWJ; Repping S; van der Veen F; Mochtar MH
    BMJ Open; 2017 May; 7(5):e015680. PubMed ID: 28550023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
    Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
    Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
    Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
    Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.